Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?
HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy
A CCR2-V64I polymorphism affects stability of CCR2A isoform
Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor
Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection
Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients
The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior
Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men
HIV-1 disease progression and fertility
HIV risk and condom use in the adult heterosexual population in France between 1992 and 2001
The longer the better? Four years of durable, initially boosted protease treatment
Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6–12 months of commencing nucleoside reverse transcriptase inhibitor therapy
Minor nef gene alterations after human HIV-DNA immunisation
Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients
Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients
Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology
Yellow fever vaccine is safe and effective in HIV-infected patients
Coronavirus infection in an AIDS patient
`DOTS’ and ‘DOT’ for delivering antiretroviral therapy in resource-poor countries
Stable drug supply and distribution in an integrated healthcare delivery system, but unconfirmed need for daily witnessed dosing
Political and socioeconomic instability
HIV optimism does not explain increases in high-risk sexual behaviour among gay men in Scotland